TrakCel
TrakCel provides OCELLOS, a Salesforce-based orchestration platform for cell and gene therapy manufacturers and treatment centers, enabling end-to-end chain of identity and custody tracking, scheduling, and partner integration across clinical and commercial supply chains in 18 countries.
- Company typePrivate
- Founded2012
- HeadquartersCardiff, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What TrakCel does
TrakCel is a UK-headquartered (Cardiff) software company founded in 2012 that builds OCELLOS, a second-generation advanced therapy orchestration platform purpose-built for cell and gene therapy (CGT) manufacturers. OCELLOS is delivered natively on Salesforce.com, extended via a MuleSoft-powered Integration Hub, and orchestrates the end-to-end patient-to-product journey — including Chain of Identity (COI) and Chain of Custody (COC) tracking, patient enrollment, scheduling, manufacturing coordination, courier booking, labelling, and administration — using a "clicks not code" modular configuration methodology. As of Q3 2025, OCELLOS is live at 350+ sites across 18 countries with 3,000+ trained users, 20+ therapies (including 5 commercial), 1,000+ enrolled patients, and is available in six languages.
TrakCel monetizes primarily through multi-year SaaS subscriptions across three OCELLOS tiers (Blueprint, Configured, Self-Config), supplemented by an OCELLOS Pay-As-You-Go offering for emerging biotechs (launched October 2025), a SAP CGTO-integrated bundle, and adjacent modules including the CGT Gateway (treatment-center unified access layer), the Therapy Command Center, and the TrakCel Connected Chain. Revenue is augmented by TrakCel Consulting Services and SI & Digital Transformation Services for configuration, validation, and commercial-launch support. Go-to-market combines direct enterprise field sales, a CRO/CDMO/logistics channel partner ecosystem, Salesforce AppExchange marketplace listing, and event-driven demand generation across Advanced Therapies Congress, CAR-TCR, and Cell & Gene Therapy World Asia.
The company is privately held and founder-controlled (Ravi Nalliah, CEO; Dr. Matthew Lakelin and Dr. Akshay Peer as co-founders). Strategic shareholders include Cencora (formerly AmerisourceBergen) and Labcorp from a 2021 funding event, alongside earlier backing from Telegraph Hill Partners and Catalyst Growth Partners in 2016. TrakCel holds ISO/IEC 27001 certification (achieved 2026), is named to The Sunday Times 100 Tech (2025), and was recognized by The Scientist as a Top 10 Innovation (2022). The company operates offices in Cardiff (UK) and San Francisco (US) and reports 11–50 employees.
TrakCel firmographics
Firmographics- Name
- TrakCel
- Legal name
- TrakCel
- Website
- https://trakcel.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TrakCel provides OCELLOS, a Salesforce-based orchestration platform for cell and gene therapy manufacturers and treatment centers, enabling end-to-end chain of identity and custody tracking, scheduling, and partner integration across clinical and commercial supply chains in 18 countries.
- Ownership category
- akta.pro rank
TrakCel industry classification
Industry- Product category
- Cell and Gene Therapy Orchestration Software
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Cell Therapy CDMO (HLAGABAD)
Keywords
Where TrakCel is headquartered
LocationHeadquarters
- HQ city
- Cardiff
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
TrakCel business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- OCELLOS Platform Subscription: SaaS subscription model for the OCELLOS orchestration platform available in Blueprint, Configured, and Self-Config deployment options. Supports clinical trial and commercial stage therapies.
- OCELLOS Pay-As-You-Go (PAYG): Rapid, affordable orchestration for emerging biotechs with pay-as-you-go pricing model for early-stage companies
- Professional Services and SI: System implementation, configuration, onboarding, and digital transformation consulting services including commercial launch support, technology architecture, patient services implementation, and quality compliance
- Consulting Services: Expert consulting services for COI strategy, data protection compliance, label design, supply chain risk assessment, and SaaS validation within pharma
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | OCELLOS Blueprint - Off-the-shelf configuration for early stage/clinical clients |
| Subscription | Multi-year contract | OCELLOS Configured - Additional configuration beyond Blueprint |
| Subscription | Multi-year contract | OCELLOS with Self-Config - Customer-administered configuration |
| Usage-based | Pay-as-you-go | OCELLOS Pay-As-You-Go (PAYG) |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
TrakCel product offering
Product offeringCore offering
TrakCel develops and sells OCELLOS, a Salesforce-powered, modular orchestration platform purpose-built for cell and gene therapy manufacturers. The platform digitizes and coordinates the end-to-end advanced therapy value chain — patient enrollment, scheduling, manufacturing, cryogenic logistics, and final product administration — while enforcing Chain of Identity and Chain of Custody. TrakCel also offers SI/Digital Transformation implementation services and TrakCel Consulting Services covering COI/COC strategy, regulatory compliance, label design, and SaaS validation.
Product overview
TrakCel offers OCELLOS, a modular, Salesforce-powered advanced therapy orchestration platform designed for cell and gene therapy manufacturers. The platform comprises multiple product tiers including OCELLOS (core platform), OCELLOS Blueprint (off-the-shelf configuration), OCELLOS Configured (tailored customization), OCELLOS with SAP CGTO Integration, OCELLOS Pay-As-You-Go (for emerging biotechs), and OCELLOS Core (for early-stage development). Supporting modules include Gateway (unified site access), CGT Gateway (HCP access), and Therapy Command Center (operations visibility). The portfolio is complemented by TrakCel Consulting Services and SI & Digital Transformation Services for implementation and optimization. OCELLOS is available on Salesforce AppExchange and supports autologous, allogeneic, and personalized cancer vaccine therapies across clinical and commercial settings.
Differentiator
Problem solved
Functional benefit
Products and services
- OCELLOS Modular, Salesforce-powered advanced therapy orchestration platform for cell and gene therapy manufacturers, providing end-to-end visibility from patient enrollment through manufacturing, logistics, and final product delivery with full Chain of Identity and Chain of Custody tracking. Available on Salesforce AppExchange, operational at 350+ sites across 18 countries supporting 20+ therapies.
- OCELLOS Core OCELLOS Core orchestration product designed for early-stage personalized cell therapy development, supporting both autologous and allogeneic therapies in clinical trial settings.
- OCELLOS Pay-As-You-Go Rapid, affordable off-the-shelf OCELLOS orchestration with pay-as-you-go pricing for emerging biotechs, providing established best-practice workflows and faster adoption without multi-year enterprise commitments.
- OCELLOS with SAP CGTO Integration Combined offering integrating OCELLOS with the SAP Cell and Gene Therapy Orchestration (CGTO) module, providing a best-in-class HCP portal backed by SAP for order intake, management, invoicing, real-time updates, exception handling, and improved data governance.
- SI & Digital Transformation Services System implementation and digital transformation services supporting organizations from clinical to commercial stage, including configuration, validation, data migration, training, commercial launch support, technology architecture, patient services implementation, and quality compliance.
- TrakCel Consulting Services Expert consultancy covering Chain of Identity and Chain of Custody strategy, data protection compliance, label design and compliance, supply chain risk assessment, and SaaS validation within the pharmaceutical industry.
Quantifiable outcome
- Up to 50+ hours saved per week by CROs eliminating manual coordination
- +2 more outcomes
Companies that use TrakCel
Customer profileNamed customers2 records
Segments8 records
Ideal customer profiles5 records
TrakCel technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration17 records
Feature10 records
TrakCel partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, strategic and minor.
- LonzacoreFull integration with Lonza's MODA-ES manufacturing execution system to ensure smooth data flow between scheduling, batch execution and clinical operations. Integration eliminates manual handoffs and provides consistent visibility across manufacturing and trial teams.
- KörbercoreIntegration with Körber's PAS-X MES platform enables automated exchange of scheduling and manufacturing data. Partnership provides visibility within manufacturing and fits into TrakCel's orchestration across the wider supply chain.
- BarTender (Seagull Scientific)coreCompliant label generation through BarTender software enabling consistent, compliant labels at the click of a button. Labels populate patient-specific information into approved templates regardless of location, language or treatment.
- BiocaircoreSpecialty courier integration for automated shipment bookings, collection instructions and real-time shipment updates. Partnership provides full visibility and integration within the complex CGT supply chain.
- QuickSTATcoreIntegration with Quick Specialized Healthcare Logistics for automated courier bookings and tracking. Partnership critical for time-sensitive transport of cell therapy materials.
- MarkencoreIntegration with Marken's global network of 49 sites including cryogenic service stations and GPS tracking technology for 24/7 monitoring of cell therapy shipments.
- World CouriercoreGlobal specialty courier integration for cell and gene therapy logistics providing on-demand access to cell therapy companies as they move through clinical trials to scaled production.
- CencoracoreIntegration with patient hub services from Cencora for real-time patient eligibility and benefits verification, live transmission of patient schedule information to case managers, and improved speed-to-therapy.
- Cardinal HealthcoreIntegration with Cardinal Health patient hub services providing patient access and reimbursement solutions as part of integrated supply chain for commercial therapies.
- Be The Match BioTherapiesstrategicCollaboration to develop custom solutions for individual programs and patient populations. Shared goal of ensuring cell and gene therapies can be developed efficiently and delivered safely to patients.
- MuleSoftcoreIntegration platform powering TrakCel's Integration Hub for standardized API connectivity. Enables secure, validated data exchange across all internal and external partners.
- ZSminorAnalytics and consulting partnership to deploy expertise helping the industry shift to proactive, predictive analyses that identify and mitigate challenges in cell therapy orchestration.
- SalesforcecorePlatform foundation for OCELLOS - second-generation cellular orchestration platform built on Salesforce Health Cloud and available on Salesforce AppExchange.
Scale indicators11 records
Recent moves7 records
Expansion highlights8 records
TrakCel competitors and assessment
Company assessmentBroad incumbents
- Salesforce Health Cloud: Healthcare-specific extension of the Salesforce platform that underpins TrakCel's OCELLOS. Comparable as the platform-of-record and a potential competitive incumbent if Salesforce expands native orchestration capabilities within Health Cloud or AppExchange.
- MasterControl: Provider of quality management, manufacturing execution, and compliance software for life sciences, including CGT manufacturers. Comparable as an incumbent offering overlapping capabilities in QMS, validation, and supply-chain documentation relevant to TrakCel's customers.
- LabVantage Solutions: Laboratory information management system (LIMS) provider serving pharmaceutical and biotech customers, including cell and gene therapy developers. Comparable as an adjacent incumbent whose informatics footprint could be extended into CGT chain-of-custody and sample tracking use cases.
- Veeva Systems: Dominant cloud software provider for the life sciences industry across CRM, clinical, regulatory, and quality. Comparable as a broader incumbent in pharma enterprise software with potential to bundle CGT orchestration into its platform, posing a competitive threat from above.
- SAP Life Sciences: Enterprise ERP vendor that has launched a dedicated Cell and Gene Therapy Orchestration (CGTO) module that TrakCel integrates with. Represents the most direct large-platform competitive threat, leveraging SAP's installed base across pharma to bundle CGT orchestration.
- Dassault Systèmes BIOVIA: Life sciences R&D, manufacturing, and quality software suite within Dassault Systèmes. Comparable as a broad incumbent whose scientific informatics and lab-to-manufacturing capabilities could be extended into CGT orchestration workflows.
Direct peers
- Vineti: Pioneer in CGT orchestration software for cell therapy manufacturers and treatment centers, offering patient scheduling, manufacturing coordination, and chain-of-custody tracking. Closest direct competitor to OCELLOS in scope and target buyer, now operating within Autolus Therapeutics' ecosystem.
- Hypertrust Patient Data Care: Germany-based independent software vendor specializing in chain-of-custody and chain-of-identity orchestration for advanced therapy medicinal products. Direct competitor to TrakCel in CGT supply-chain orchestration, with comparable focus on autologous and allogeneic therapies and treatment-center workflows.
Emerging players
- Cellares: Emerging cell therapy manufacturing automation company building integrated cell therapy platforms. Relevant as a next-generation CGT manufacturing technology provider whose factory-of-the-future approach intersects with TrakCel's orchestration domain.
- Ori Biotech: Early-stage company developing automated cell and gene therapy manufacturing platforms with integrated process control. Adjacent emerging player whose manufacturing automation roadmap could overlap with TrakCel's orchestration layer in CGT production environments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
TrakCel social profiles
Digital presenceTrakCel compliance and trust
Trust signalCompliance1 record
TrakCel financial estimates
Financial estimateRevenue estimate
Valuation estimate
TrakCel leadership team
Management profileNumber of profiles
Profiles7 records
TrakCel subsidiaries and ownership
Company hierarchySubsidiaries1 record
TrakCel funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TrakCel M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TrakCel
What does TrakCel do?
TrakCel develops and sells OCELLOS, a Salesforce-powered, modular orchestration platform purpose-built for cell and gene therapy manufacturers. The platform digitizes and coordinates the end-to-end advanced therapy value chain — patient enrollment, scheduling, manufacturing, cryogenic logistics, and final product administration — while enforcing Chain of Identity and Chain of Custody. TrakCel also offers SI/Digital Transformation implementation services and TrakCel Consulting Services covering COI/COC strategy, regulatory compliance, label design, and SaaS validation.
Is TrakCel a public or private company?
TrakCel is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TrakCel founded?
TrakCel was founded in 2012. It employs 11 to 50 people.
Where is TrakCel based?
TrakCel is headquartered in Cardiff, United Kingdom, in the Europe region.
How does TrakCel make money?
Four revenue lines are on record. OCELLOS Platform Subscription is the primary driver. The others are OCELLOS Pay-As-You-Go (PAYG), professional Services and SI and consulting Services.
Who are TrakCel's main competitors?
Broad incumbents on record are Salesforce Health Cloud, MasterControl, LabVantage Solutions, Veeva Systems, SAP Life Sciences and Dassault Systèmes BIOVIA. Direct peers are Vineti and Hypertrust Patient Data Care. Emerging players are Cellares and Ori Biotech.
Does TrakCel have an API?
No public API is recorded for TrakCel.
What industry is TrakCel in?
TrakCel's product category is Cell and Gene Therapy Orchestration Software. Its primary akta.pro industry code is HLAGABAD, Cell Therapy CDMO. Its NAICS code is 5132 and its SIC code is 8742.